Featured Research

from universities, journals, and other organizations

Prenatal Multivitamins Fail Industry Test For Folic Acid

Date:
August 4, 1997
Source:
University Of Maryland At Baltimore
Summary:
Studies show that supplementing a mother's diet with folic acid before and during pregnancy can reduce incidences of neural tube birth defects in children. But researchers at the University of Maryland School of Pharmacy, found poor folic acid dissolution in six prenatal prescription multivitamins they tested, raising questions as to whether or not absorption by the body is complete.

BALTIMORE--Studies show that supplementing a mother's diet withfolic acid before and during pregnancy can reduce incidences ofneural tube birth defects in children. But researchers at theUniversity of Maryland School of Pharmacy, found poor folic aciddissolution in six prenatal prescription multivitamins theytested, raising questions as to whether or not absorption by thebody is complete.

Stephen Hoag, Ph.D., assistant professor at the UM School ofPharmacy, says tests of nine prenatal prescription multivitaminsfound six products did not release at least 75 percent of theamount of folic acid listed on their labels in one hour, anindustry standard set in 1995.

The report, written by Hoag and co-author Ralph Shangraw, Ph.D.,professor emeritus with the UM School of Pharmacy, and HanuRamachandruni, M.S., a graduate student in the pharmacy school,was published in the July-August issue of the Journal of theAmerican Pharmaceutical Association.

"Typically vitamins, including folic acid, are more readilyabsorbed in the upper gastrointestinal tract, just beyond thestomach," says Hoag. "Not meeting the standard of dissolvingwithin an hour highlights a potential problem with theseproducts. The amount of folic acid available for optimalabsorption in the body could be inadequate."

While dissolution of a substance does not guarantee absorption,the researchers say it is necessary for absorption to occur.Many of the products Hoag tested missed the minimum standard bya wide margin, two released less than 25 percent of the labeledquantity.

Hoag and Shangraw say they will not name the products studiedbecause federal regulations and standards for nutritionalsupplements are changing and some manufacturers have improvedtheir products to insure proper dissolution before this researchwas published. The standards for folic acid dissolution aredeveloped by the United States Pharmacopeial Convention.Nutritional products meeting these standards can label theirproducts USP.

"Folic acid is caught in evolving regulatory policies and isregulated by the FDA as a food, not a drug," says Shangraw."Only products that bear a health claim stating that increasedfolic acid intake before conception and during early pregnancyreduces the risk of having a baby with neural tube defects, arerequired to meet a USP folic acid dissolution standard. Althoughthe products tested contained 1 mg of folic acid, were clearlylabeled prenatal vitamins and sold by prescription only, theytechnically did not have to meet dissolution standards. It seemsreasonable that they should," says Shangraw.

"For drugs it is standard to analyze blood levels to make surethe substance is absorbed. You must substantiate purity, safetyand efficacy with data in a drug application to the FDA. Butbecause nutritional supplements are regulated as a food, thestandards are different," says Hoag.

"Scientifically we know about how drugs are absorbed by thebody, but there has been very little research intobioavailability from vitamin tablets or capsules," saysShangraw.

Hoag and Shangraw say people should not stop taking theirvitamins. "Vitamins should preferably be taken with food andplenty of fluids. Any amount absorbed is beneficial, and no oneis sure what amount of folic acid is needed to reduce neuraltube defects," says Shangraw.

-30-


Story Source:

The above story is based on materials provided by University Of Maryland At Baltimore. Note: Materials may be edited for content and length.


Cite This Page:

University Of Maryland At Baltimore. "Prenatal Multivitamins Fail Industry Test For Folic Acid." ScienceDaily. ScienceDaily, 4 August 1997. <www.sciencedaily.com/releases/1997/08/970804081329.htm>.
University Of Maryland At Baltimore. (1997, August 4). Prenatal Multivitamins Fail Industry Test For Folic Acid. ScienceDaily. Retrieved October 21, 2014 from www.sciencedaily.com/releases/1997/08/970804081329.htm
University Of Maryland At Baltimore. "Prenatal Multivitamins Fail Industry Test For Folic Acid." ScienceDaily. www.sciencedaily.com/releases/1997/08/970804081329.htm (accessed October 21, 2014).

Share This



More Science News

Tuesday, October 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Thanks, Marty McFly! Hoverboards Could Be Coming In 2015

Thanks, Marty McFly! Hoverboards Could Be Coming In 2015

Newsy (Oct. 21, 2014) If you've ever watched "Back to the Future Part II" and wanted to get your hands on a hoverboard, well, you might soon be in luck. Video provided by Newsy
Powered by NewsLook.com
CDC Revamps Ebola Guidelines After Criticism

CDC Revamps Ebola Guidelines After Criticism

Newsy (Oct. 21, 2014) The Centers for Disease Control and Prevention have issued new protocols for healthcare workers interacting with Ebola patients. Video provided by Newsy
Powered by NewsLook.com
Robots to Fly Planes Where Humans Can't

Robots to Fly Planes Where Humans Can't

Reuters - Innovations Video Online (Oct. 21, 2014) Researchers in South Korea are developing a robotic pilot that could potentially replace humans in the cockpit. Unlike drones and autopilot programs which are configured for specific aircraft, the robots' humanoid design will allow it to fly any type of plane with no additional sensors. Ben Gruber reports. Video provided by Reuters
Powered by NewsLook.com
WHO: Ebola Vaccine Trials to Start a in January

WHO: Ebola Vaccine Trials to Start a in January

AP (Oct. 21, 2014) Tens of thousands of doses of experimental Ebola vaccines could be available for "real-world" testing in West Africa as soon as January as long as they are deemed safe in soon to start trials, the World Health Organization said Tuesday. (Oct. 21) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins